Vivo Capital, LLC: DRUG position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Vivo Capital, LLC on DRUG, newest first. How the timeline and the estimate are built.
Vivo Capital, LLC held 557,172 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-14.
the latest 13F is the newest step
- period ended2026-06-3013F 557,172 sharesChange vs previous 13F 0 shares
3.57% of the 13F portfolio, value $39,113,474.
13F-HR 0001213900-26-089935 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F/A 557,172 sharesChange vs previous 13F +55,555 shares
3.38% of the 13F portfolio, value $40,656,841.
13F-HR/A 0001213900-26-059247 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 501,617 sharesChange vs previous 13F 0 shares
2.53% of the 13F portfolio, value $39,146,191.
13F-HR 0001213900-26-016236 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 501,617 sharesChange vs previous 13F +250,045 shares
2.45% of the 13F portfolio, value $30,428,087.
13F-HR 0001213900-25-110767 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 251,572 sharesChange vs previous 13F 0 shares
0.67% of the 13F portfolio, value $6,568,545.
13F-HR 0001213900-25-075901 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 251,572 sharesChange vs previous 13F 0 shares
1.2% of the 13F portfolio, value $9,074,202.
13F-HR 0001213900-25-041737 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 251,572 sharesChange vs previous 13F not available
1.02% of the 13F portfolio, value $9,061,623.
13F-HR 0001213900-25-013306 filed by Vivo Capital, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).